Ratings by Bloom Burton & Co.
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | David Martin | Eupraxia Pharmaceuticals | EPRX | New Coverage | Buy (1) (N/A) |
14.00 (N/A) |
8.50 (7.99) |
-6% | Details |
| 1/10/2025 | Dave Martin | Repare Therapeutics | RPTX | Downgrade | Hold (3) (Buy (1)) |
N/A (N/A) |
1.28 (2.65) |
107.03% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 7 more... | |||||||||
